Element Capital Management’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-599,800
Closed -$5.97M 76
2021
Q1
$5.97M Sell
599,800
-250,200
-29% -$2.67M 1.37% 24
2020
Q4
$9.18M Buy
+850,000
New +$8.75M 0.96% 20

Other funds holding STLN

Element Capital Management's STLN Position: Q2 2021 in Review

Element Capital Management sold out of Starling Oncology Institute, Inc. Common Stock (STLN) in Q2 2021, closing a stake of 599,800 shares — an estimated $5.97M sold.

Element Capital Management first reported a position in STLN in Q4 2020 and held it in 2 quarters. The position peaked at $9.18M in Q4 2020. 53 funds tracked by Wall St. Rank hold STLN as of Q2 2021.

  • Element Capital Management reported no remaining Starling Oncology Institute, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Element Capital Management sold 599,800 Starling Oncology Institute, Inc. Common Stock shares in Q2 2021, an estimated $5.97M.
  • Element Capital Management first reported a position in Starling Oncology Institute, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Element Capital Management's Starling Oncology Institute, Inc. Common Stock position peaked at $9.18M in Q4 2020.
  • 53 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q2 2021.

Based on Element Capital Management's 13F filing for Q2 2021, filed 11 Aug 2021.